Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock

Date Announced: 02 Aug 2012

Medical laser system company expects offer to close August 7.

HAYWARD, Calif., Aug. 2, 2012 /PRNewswire/ -- Solta Medical, Inc. (SLTM) today announced that it has priced an underwritten public offering of 5,700,000 shares of its common stock at a price to the public of $2.65 per share. Net proceeds, after estimated underwriting discounts and estimated offering expenses, will be approximately $14 million. In addition, Solta Medical has granted the underwriters a 30-day option to purchase up to an additional 855,000 shares of common stock solely to cover over-allotments, if any.

The offering is expected to close on or about August 7, 2012, subject to customary closing conditions. Canaccord Genuity served as sole book-running manager and Roth Capital Partners served as co-manager for the offering.

Solta Medical currently intends to use the net proceeds from the offering for general corporate purposes.

The offering is being made to purchasers pursuant to a registration statement (File No. 333-181074) previously filed with and declared effective by the Securities and Exchange Commission, or SEC. A prospectus supplement and accompanying prospectus describing the terms of the offering will be filed with the SEC. When available, copies of the prospectus supplement and accompanying prospectus may be obtained by contacting Canaccord Genuity Inc., Attention: Syndicate Department, 99 High Street, 12th Floor, Boston, Massachusetts 02110, or by telephone at (617) 371-3900. Electronic copies of the prospectus supplement and accompanying prospectus will also be available free of charge on the website of the SEC at www.sec.gov.

Source: Solta Medical

Contact

E-mail: via web site

Web Site: www.solta.com